Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Regulatory Toxicology and Pharmacology : RTP|February 29, 2012
Application of computational toxicological approaches in human health risk assessment. I. A tiered surrogate approachNina Ching Yi Wang, Q Jay Zhao, Scott C Wesselkamper, et al.
Annals of Neurology|March 23, 2001
McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findingsH H Jung, M Hergersberg, S Kneifel, et al.
Oncogene|May 29, 1999
cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell linesC H Rhee, K Hess, J Jabbur, et al.
International Journal of Oncology|May 11, 2011
P53 alterations show significant correlation with gene amplification and s-phase index in breast-cancerM Cervantes, H Zhou, A Sahin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumorsS E Kaba, A P Kyritsis, K Hess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancerF R Spitz, G G Giacco, K Hess, et al.
Angewandte Chemie (International Ed. in English)|May 22, 2014
Synthetic polyester from algae oilPhilipp Roesle, Florian Stempfle, Sandra K Hess, et al.
Journal of Animal Science|June 16, 2018
Genetic relationships of antibody response, viremia level, and weight gain in pigs experimentally infected with porcine reproductive and respiratory syndrome virus1Andrew S Hess, Ben R Trible, Melanie K Hess, et al.
Molecular Cancer Research : MCR|September 30, 2008
2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-activated protein kinase pathwaysSupriya Shah, Janet K Hess-Wilson, Siobhan Webb, et al.
Cancer Research|July 10, 2007
Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cellsAnkur Sharma, Clay E S Comstock, Erik S Knudsen, et al.
Pageof 14